Detalhe da pesquisa
1.
A phase 2 study of ibrutinib maintenance following first-line high-dose methotrexate-based chemotherapy for elderly patients with primary central nervous system lymphoma.
Cancer
; 129(24): 3905-3914, 2023 12 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-37572086
2.
Real-world experience with belantamab mafodotin therapy for relapsed/refractory multiple myeloma: A multicentre retrospective study.
Br J Haematol
; 200(1): 45-53, 2023 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-36205375
3.
Thrombosis in Pregnant Women with Hematological Malignancies: A Case-Based Review.
Semin Thromb Hemost
; 49(4): 348-354, 2023 Jun.
Artigo
em Inglês
| MEDLINE | ID: mdl-36535649
4.
Incidence and risk factors for central nervous system relapse in patients with primary mediastinal large B-cell lymphoma in the rituximab era.
Hematol Oncol
; 41(1): 97-107, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36314897
5.
In chronic lymphocytic leukemia, activation of the thrombopoietin receptor promotes T-cell inhibitory properties, contributing to immunosuppression.
Eur J Haematol
; 110(4): 371-378, 2023 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-36478591
6.
The role of additional chemotherapy prior to autologous HCT in patients with relapse/refractory DLBCL in partial remission-A retrospective multicenter study.
Eur J Haematol
; 110(2): 149-156, 2023 Feb.
Artigo
em Inglês
| MEDLINE | ID: mdl-36251268
7.
Humoral serological response to the BNT162b2 vaccine is abrogated in lymphoma patients within the first 12 months following treatment with anti-CD2O antibodies.
Haematologica
; 107(3): 715-720, 2022 03 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34320790
8.
Polatuzumab-based regimen or CAR T cell for patients with refractory/relapsed DLBCL-a matched cohort analysis.
Ann Hematol
; 101(4): 755-762, 2022 Apr.
Artigo
em Inglês
| MEDLINE | ID: mdl-35083525
9.
Romidepsin treatment for relapsed or refractory peripheral and cutaneous T-cell lymphoma: Real-life data from a national multicenter observational study.
Hematol Oncol
; 37(5): 569-577, 2019 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-31674027
10.
Characteristics, management and outcome of DLBCL patients, presenting with simultaneous systemic and CNS disease at diagnosis: A retrospective multicenter study.
Am J Hematol
; 94(9): 992-1001, 2019 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-31211434
11.
Heparanase-neutralizing antibodies attenuate lymphoma tumor growth and metastasis.
Proc Natl Acad Sci U S A
; 113(3): 704-9, 2016 Jan 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-26729870
12.
Chronic lymphocytic leukemia cells acquire regulatory B-cell properties in response to TLR9 and CD40 activation.
Cancer Immunol Immunother
; 67(5): 739-748, 2018 May.
Artigo
em Inglês
| MEDLINE | ID: mdl-29450641
13.
Modification of initial therapy in early and advanced Hodgkin lymphoma, based on interim PET/CT is beneficial: a prospective multicentre trial of 355 patients.
Br J Haematol
; 178(5): 709-718, 2017 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-28589704
14.
Attenuated humoral immune response following anti-SARS-CoV-2 vaccine in heavily pretreated patients with multiple myeloma and AL amyloidosis.
Am J Hematol
; 96(12): E475-E478, 2021 12 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-34622495
15.
Brain-derived neurotrophic factor as a potential biomarker of chemotherapy-induced peripheral neuropathy and prognosis in haematological malignancies; what we have learned, the challenges and a need for global standardization.
Br J Haematol
; 191(1): 17-18, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32557540
16.
Thrombosis and Hemostasis Issues in Cancer Patients with COVID-19.
Semin Thromb Hemost
; 46(7): 785-788, 2020 10.
Artigo
em Inglês
| MEDLINE | ID: mdl-32785920
17.
Prospective comparison of early bone marrow evaluation on day 5 versus day 14 of the "3 + 7" induction regimen for acute myeloid leukemia.
Am J Hematol
; 90(12): 1159-64, 2015 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-26435038
18.
Bone marrow blast elimination by the fifth day of 7 + 3 induction is the strongest predictor of potential cure in patients with acute myeloid leukemia younger than 61 years of age: A long-term follow-up of a multi-center prospective study.
Am J Hematol
; 95(1): E3-E5, 2020 01.
Artigo
em Inglês
| MEDLINE | ID: mdl-31591736
19.
A 14-Year Experience in the Management of Patients with Acquired Immune Thrombotic Thrombocytopenic Purpura in Northern Israel.
Acta Haematol
; 134(3): 170-6, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-25997685
20.
Brain derived neurotropic factor single nucleotide polymorphism Val66Met and serum protein levels are associated with development of vincristine-induced peripheral neuropathy in patients with lymphoma.
Br J Haematol
; 185(1): 175-177, 2019 04.
Artigo
em Inglês
| MEDLINE | ID: mdl-29938784